Population Pharmacokinetics and Dosing Optimization of Piperacillin in Elderly Patients with Pneumonia in the Intensive Care Unit
The Journal of Clinical Pharmacology · 2025
DOI: 10.1002/jcph.70089 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2025. Verfasst von Jing Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Institute of Clinical Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory …. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Models, Biological, Piperacillin, Pneumonia. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Key R&D Program of China, Innovation and Development Joint Natural Science Foundation of Shandong Province, Distinguished Expert of Taishan Scholars Shandong Province Project.
Themen: Intensivpflege
Abstract (Originalsprache)
Piperacillin/tazobactam is the first‐line treatment for pneumonia in elderly patients. However, there are differences in dosing regimens and infusion times among different centers. We aimed to evaluate the population pharmacokinetics of piperacillin in elderly patients with pneumonia and optimize the dosing regimens. This was a prospective pharmacokinetic (PK) study of piperacillin/tazobactam in elderly patients with pneumonia using an opportunistic sampling design. The blood concentration of piperacillin was determined by high‐performance liquid chromatography. A population PK model was constructed using NONMEM software, and its predictive performance was further validated in a separate test cohort. The final population PK model was used for dose optimization. A total of 151 blood samples from 73 patients were used to develop a population PK model, and 60 concentrations of therapeutic drug monitoring from 22 patients were used for model validation. A one‐compartment model with first‐order elimination was established. Covariate analysis showed that eGFR was the only covariate. Monte Carlo simulation results showed that for pathogens with MIC values of 8 and 16 mg/L, the dosing regimen (4000 mg every 6/8 h administered 30 min) used in this study resulted in PTAs of 23.5%‐64.3%. The PTAs of the dosing regimen 4000 mg every 6 h administered by 4‐h infusion for patients with different levels of renal function exceeded 90% (90.7%‐99.8%), except for patients with eGFR ≥ 50 mL/min/1.73 m 2 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Institute of Clinical Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, School of Pha…
- Department of Pharmacy, The Second Hospital of Shandong University, Jinan, China.
- Department of Intensive Care, The Second Hospital of Shandong University, Jinan, China.
- Division of Clinical Pharmacology, Children's National Hospital, Washington, DC, USA.
- Departments of Pediatrics, Pharmacology & Physiology, Genomics and Precision Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC, USA.
- Department of Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland.
ORCID-Profile: Wei Zhao
Förderung
- National Key R&D Program of China
- Innovation and Development Joint Natural Science Foundation of Shandong Province
- Distinguished Expert of Taishan Scholars Shandong Province Project
- Distinguished Young and Middle-aged Scholar of Shandong University
- National Key Research and Development Program of China
Zitieren
APA
Sun, J., Yang, C., Tang, B. H., Hao, G. X., van den Anker, J., Wu, Y. E., Sun, D. Q., Zheng, Y., & Zhao, W. (2025). Population Pharmacokinetics and Dosing Optimization of Piperacillin in Elderly Patients with Pneumonia in the Intensive Care Unit. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70089
Vancouver
Sun J, Yang C, Tang BH, Hao GX, van den Anker J, Wu YE, et al. Population Pharmacokinetics and Dosing Optimization of Piperacillin in Elderly Patients with Pneumonia in the Intensive Care Unit. The Journal of Clinical Pharmacology. 2025. doi:10.1002/jcph.70089
BibTeX
@article{Sun2025,
author = {Sun, Jing and Yang, Chuang and Tang, Bo-Hao and Hao, Guo-Xiang and van den Anker, John and Wu, Yue-E and Sun, De-Qing and Zheng, Yi and Zhao, Wei},
title = {Population Pharmacokinetics and Dosing Optimization of Piperacillin in Elderly Patients with Pneumonia in the Intensive Care Unit},
journal = {The Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1002/jcph.70089}
}
EUVIMED